Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

The unconventional Di Bella cancer treatment. A reflection on the Italian experience. The Italian Study Group for the Di Bella Multitherapy Trials.

Traversa G, Maggini M, Menniti-Ippolito F, Bruzzi P, Chiarotti F, Greco D, Spila-Alegiani S, Raschetti R, Benagiano G.

Cancer. 1999 Nov 15;86(10):1903-11. No abstract available.

PMID:
10570412
3.

[Experimentation with Di Bella polychemotherapy in Tuscany].

Orlandini C, Amunni G, Conte PF, Francini G, Rossini GC, Vanni D; Gruppo di riferimento regionale per la sperimentazione multiterapia Di Bella Membri del Gruppo..

Epidemiol Prev. 2000 Sep-Oct;24(5):209-12. Italian.

PMID:
11189475
4.

An unconventional cancer treatment lacking clinical efficacy remains available to Italian cancer patients.

Merlo DF, Beccaro M, Costantini M; Italian Survey of the Dying of Cancer Study Group..

Tumori. 2008 Nov-Dec;94(6):830-2.

5.

[Evaluation study of the opinions on the Di Bella multi-therapy (MDB) of tumor patients].

Di Filippo F, Serraino D, Tirelli U.

Clin Ter. 1998 Jul-Aug;149(4):261-5. Italian.

PMID:
9866886
6.

[End of the Di Bella cancer therapy].

Ernst E.

MMW Fortschr Med. 1999 Jun 24;141(25):22-3. German. No abstract available.

PMID:
10897900
7.

Medical treatment of colorectal cancer in elderly (>70 years): GISCAD experience and future perspectives. Italian Group for the Study of Digestive Tract Cancer.

Beretta GD, Ferrari VD, Barni S, Pancera G, Labianca R.

Tumori. 2002 Jan-Feb;88(1 Suppl 1):S109-12. No abstract available.

PMID:
11989900
8.

Adjuvant systemic therapies in patients with colorectal cancer: an audit on clinical practice in Italy.

Drug Utilization Review Team in Oncology..

Tumori. 2005 Nov-Dec;91(6):472-6.

PMID:
16457144
9.

[Colonic cancer. Adjuvant therapy: the Italian experience].

Cascinu S, Salvagni S, Camisa R, Gasparro D, Biscari L, Pucci F, Leonardi F, Franciosi V.

Tumori. 2001 Jan-Feb;87(1 Suppl 1):S83-4. Italian. No abstract available.

PMID:
11300038
10.

A variant of ProMACE-CytaBOM chemotherapy for non-Hodgkin's lymphoma with threefold higher drug dose size but identical cumulative dose intensity. A pilot study of the Italian lymphoma study group (GISL).

Gobbi PG, Ghirardelli ML, Avanzini P, Baldini L, Quarta G, Stelitano C, Broglia C, Loni C, Silingardi V, Ascari E.

Haematologica. 2000 Mar;85(3):263-8.

11.

Inappropriate doses of chemotherapy in Italian breast cancer patients enrolled in clinical trials.

Ballatori E, Roila F, Ruggeri B, De Angelis V, Porzio G, Marchetti P; Italian Group for Antiemetic Research..

Tumori. 2007 Nov-Dec;93(6):540-3.

12.

Multicycle dose-intensive chemotherapy for women with high-risk primary breast cancer: results of International Breast Cancer Study Group Trial 15-95.

International Breast Cancer Study Group., Basser RL, O'Neill A, Martinelli G, Green MD, Peccatori F, Cinieri S, Coates AS, Gelber RD, Aebi S, Castiglione-Gertsch M, Viale G, Price KN, Goldhirsch A.

J Clin Oncol. 2006 Jan 20;24(3):370-8.

PMID:
16421418
13.

A multicentre phase II study of carboplatin plus pegylated liposomal doxorubicin as first-line chemotherapy for patients with advanced or recurrent endometrial carcinoma: the END-1 study of the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies) group.

Pignata S, Scambia G, Pisano C, Breda E, Di Maio M, Greggi S, Ferrandina G, Lorusso D, Zagonel V, Febbraro A, Riva N, De Rosa V, Gallo C, Perrone F; Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies Group..

Br J Cancer. 2007 Jun 4;96(11):1639-43. Epub 2007 May 8.

14.

Neoadjuvant oxaliplatin-based chemotherapy for liver metastases from colorectal cancer. An Italian survey.

Zaniboni A, Torri V, Tinazzi A, Codignola C, Faggiuolo R, Sperti E.

Tumori. 2005 Sep-Oct;91(5):383-7.

PMID:
16459633
15.

A multicenter retrospective study of chemotherapy for recurrent intracranial ependymal tumors in adults by the Gruppo Italiano Cooperativo di Neuro-Oncologia.

Brandes AA, Cavallo G, Reni M, Tosoni A, Nicolardi L, Scopece L, Franceschi E, Sotti G, Talacchi A, Turazzi S, Ermani M.

Cancer. 2005 Jul 1;104(1):143-8.

16.

Comparison of incidence of sepsis in cancer patients that underwent systemic or loco-regional chemotherapy.

Della Seta R, Pacetti P, Mambrini A, Santorsa T, Flora R, Orlandi M, Cantore M.

Infez Med. 2005 Dec;13(4):251-4.

17.
18.

Bortezomib in multiple myeloma: treatment and retreatment. A single center experience.

Warzocha K, Kraj M, Pogłód R, Kwaśniak B.

Acta Pol Pharm. 2008 Nov-Dec;65(6):753-6. No abstract available.

19.

Management of Frail and Not-Frail elderly cancer patients in a hospital-based geriatric oncology program.

Basso U, Tonti S, Bassi C, Brunello A, Pasetto LM, Scaglione D, Falci C, Beda M, Aversa SM, Stefani M, Castegnaro E, Tamellini F, Monfardini S.

Crit Rev Oncol Hematol. 2008 May;66(2):163-70. doi: 10.1016/j.critrevonc.2007.12.006. Epub 2008 Feb 19.

PMID:
18243726
20.

Multimodality therapy for non-small cell lung cancer (NSCLC): ongoing Italian experiences in the adjuvant and neoadjuvant settings.

Crinò L, Cappuzzo F.

Lung Cancer. 2001 Dec;34 Suppl 3:S45-7. No abstract available.

PMID:
11740993

Supplemental Content

Support Center